US Drug Recall Register

FDA Drug Recalls

14,801 recalls, newest first

Class II · Moderate risk Terminated

GLYCERIN STERILE 99% 2ML VIAL and 5ML VIAL

Reason Lack of Assurance of Sterility: FDA inspection revealed insanitary conditions at the facility.

Pharmacy Innovations D-0212-2023
Class II · Moderate risk Terminated

Glycerin 72%

Reason Lack of Assurance of Sterility: FDA inspection revealed insanitary conditions at the facility.

Pharmacy Innovations D-0211-2023
Class II · Moderate risk Terminated

Glutathione L Reduced 100mg/Ml

Reason Lack of Assurance of Sterility: FDA inspection revealed insanitary conditions at the facility.

Pharmacy Innovations D-0210-2023
Class II · Moderate risk Terminated

Gentamicin Bladder 0.08mg/Ml

Reason Lack of Assurance of Sterility: FDA inspection revealed insanitary conditions at the facility.

Pharmacy Innovations D-0209-2023
Class II · Moderate risk Terminated

Flurbiprofen -Corn Oil- 0.04%

Reason Lack of Assurance of Sterility: FDA inspection revealed insanitary conditions at the facility.

Pharmacy Innovations D-0208-2023
Class II · Moderate risk Terminated

Ethyl Alcohol 95%

Reason Lack of Assurance of Sterility: FDA inspection revealed insanitary conditions at the facility.

Pharmacy Innovations D-0207-2023
Class II · Moderate risk Terminated

Estradiol Cyp/Test Cyp- Ss Oil- 2mg/50mg/Ml

Reason Lack of Assurance of Sterility: FDA inspection revealed insanitary conditions at the facility.

Pharmacy Innovations D-0206-2023
Class II · Moderate risk Terminated

Estradiol 0.05% OPH Solution

Reason Lack of Assurance of Sterility: FDA inspection revealed insanitary conditions at the facility.

Pharmacy Innovations D-0205-2023
Class II · Moderate risk Terminated

Edetate Disodium

Reason Lack of Assurance of Sterility: FDA inspection revealed insanitary conditions at the facility.

Pharmacy Innovations D-0204-2023
Class II · Moderate risk Terminated

Edetate Calcium Disodium 400MG/ML

Reason Lack of Assurance of Sterility: FDA inspection revealed insanitary conditions at the facility.

Pharmacy Innovations D-0203-2023
Class II · Moderate risk Terminated

Dexamethasone 16mg/Ml

Reason Lack of Assurance of Sterility: FDA inspection revealed insanitary conditions at the facility.

Pharmacy Innovations D-0201-2023
Class II · Moderate risk Terminated

Cyclosporine

Reason Lack of Assurance of Sterility: FDA inspection revealed insanitary conditions at the facility.

Pharmacy Innovations D-0200-2023
Class II · Moderate risk Terminated

Clindamycin/EDTA Calcium 4.1667MG/0.333MG/ML

Reason Lack of Assurance of Sterility: FDA inspection revealed insanitary conditions at the facility.

Pharmacy Innovations D-0199-2023
Class II · Moderate risk Terminated

Cholecalciferol

Reason Lack of Assurance of Sterility: FDA inspection revealed insanitary conditions at the facility.

Pharmacy Innovations D-0198-2023
Class II · Moderate risk Terminated

Ceftazidime Intravitreal

Reason Lack of Assurance of Sterility: FDA inspection revealed insanitary conditions at the facility.

Pharmacy Innovations D-0197-2023
Class II · Moderate risk Terminated

Buprenorphine HCL 0.9 MG/ML

Reason Lack of Assurance of Sterility: FDA inspection revealed insanitary conditions at the facility.

Pharmacy Innovations D-0196-2023
Class II · Moderate risk Terminated

BSS Plus/Lidocaine Opth 1%

Reason Lack of Assurance of Sterility: FDA inspection revealed insanitary conditions at the facility.

Pharmacy Innovations D-0195-2023
Class II · Moderate risk Terminated

Atropine sulfate 0.05%

Reason Lack of Assurance of Sterility: FDA inspection revealed insanitary conditions at the facility.

Pharmacy Innovations D-0194-2023
Class II · Moderate risk Terminated

Apomorphine HCL 2MG/ML

Reason Lack of Assurance of Sterility: FDA inspection revealed insanitary conditions at the facility.

Pharmacy Innovations D-0193-2023
Class II · Moderate risk Terminated

Albuterol

Reason Lack of Assurance of Sterility: FDA inspection revealed insanitary conditions at the facility.

Pharmacy Innovations D-0192-2023
Class II · Moderate risk Terminated

Acetylcysteine 10% Ophthalmic Solution

Reason Lack of Assurance of Sterility: FDA inspection revealed insanitary conditions at the facility.

Pharmacy Innovations D-0191-2023
Class II · Moderate risk Terminated

5-Fluorouracil 1%

Reason Lack of Assurance of Sterility: FDA inspection revealed insanitary conditions at the facility.

Pharmacy Innovations D-0190-2023
Class II · Moderate risk Terminated

Minoxidil 0.75%

Reason Lack of Assurance of Sterility: FDA inspection revealed insanitary conditions at the facility.

Pharmacy Innovations D-0189-2023
Class II · Moderate risk Terminated

Methylcobalamin 1MG/ML

Reason Lack of Assurance of Sterility: FDA inspection revealed insanitary conditions at the facility.

Pharmacy Innovations D-0188-2023